Health Services Organization and Management HSA 500 The Pharmaceutical Industry Williams, S. J., & Torrens, P. R. (2008). Introduction to Health Services.

Slides:



Advertisements
Similar presentations
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Advertisements

© 2005 by Nelson, a division of Thomson Canada Limited. 1 Consumer Stakeholders: Product and Service Issues Search the Web The American Society for Quality.
MZC1© 2005 by Lippincott Williams & Wilkins Unit I: Foundations of Community Health Chapter 3 Roles and Settings for CHN.
EDC PHARMA SERVICES Capacity. Expertise. Solutions. Technology.
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
DRUG SAFETY RESEARCH June 16, ISSUES Pharmaceutical Industry Depends on Block Buster Model (currently ~80 BBs). Block Buster Model requires fast.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 13 Technology in Medicine.
An overview of off-label drug use Ignoring the Label Samantha Rue.
Concepts of Engineering and Technology
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Business & Society Business & Society Ethics, Sustainability, and Stakeholder Management Eighth Edition Archie B. Carroll Ann K. Buchholtz © 2012 South-Western,
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
Sabena Ahmad Iveta Smincakova Dawn Bradbury. Political:  Lighter Regulatory Controls (1960s)  Tighter Regulatory Controls on Clinical trials (1970s)
Chapter 2 Health Care Systems.
Healthcare Reforms and Pharmaceuticals Lessons from Turkey Prof. Dr. Mehtap Tatar Hacettepe University Faculty of Economics and Administrative Sciences.
Andrew Gettinger, MD, FCCP, FCCM CMIO, Office of the National Coordinator for HIT Director (acting), Office of Clinical Quality and Safety Health IT Safety.
Chapter 1 Introduction.
LAW for Business and Personal Use © 2012 Cengage Learning. All Rights Reserved. May not be scanned, copied or duplicated, or posted to a publicly accessible.
Chapter 2 Situation & Environmental Analysis. COPYRIGHT © 2002 Thomson Learning, Inc. All rights reserved. Components of a Situation Analysis... Internal.
Packaging and Labeling. Lesson Objectives Explain the functions of product packaging Identify the functions of labels Identify and explain government.
Claire Higgins Public Health Development Officer Institute of Public Health in Ireland The Driving Forces for HIA 7 th International.
Macro environment analysis on pharmaceutical industry.
Introduction Training on Safe Hospitals in Disasters.
Legal & Ethical Issues. Objectives At the completion of this session the participant will be able to: ◦ Describe the ethical principles associated with.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Horizon 2020 First reflections Tallinn
ERM and the Pharmaceutical Industry. Risk  An innate part of every aspect of life, and the business environment is of no exception  Severity, both in.
Chapter 7 Legal Aspects of Business
Biotechnology Chemical Pharmaceutical Customer Partnership
Business Administration & Management Mr. Bernstein Regulations Protecting Businesses and the Public, pp March 12, 2015.
Drug Coated Balloons for PAD William B. Newton III, MD Assistant Professor of Surgery Department of Vascular and Endovascular Surgery.
Health Economics & Policy 2 nd Edition James W. Henderson Chapter 12 Technology in Medicine Copyright 2002, South-Western, a division of Thomson Learning,
Health Services Organization and Management HSA 500 Health Care Professionals Williams, S. J., & Torrens, P. R. (2008). Introduction to Health Services.
Agencies of the Executive Branch Decisions made by any agency of the Executive Branch are considered an executive order and have the power of LAW!!!
Health Services Organization and Management HSA 500 The Future of Health Services Williams, S. J., & Torrens, P. R. (2008). Introduction to Health Services.
Health Services Organization and Management HSA 500 Ethical Issues in Public Health and Health Services Williams, S. J., & Torrens, P. R. (2008). Introduction.
Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 11 Planning Care.
© SOUTH-WESTERN  12.1 Students understand common terms & concepts and economics reasoning. Standard Address: CONTEMPORARY ECONOMICS: LESSON 3.21.
© SOUTH-WESTERNCONTEMPORARY ECONOMICS: LESSON 3.21 LESSON 3.2 Regulating the Private Sector  Explain how government, by establishing laws and regulations,
Chapter 6 legal and ethical issues Section 6.1 Government and Laws
The Nature of Business McGraw-Hill  The McGraw-Hill Companies, Inc., 2001.
By Isaac and Christy.  GMOs are regulated by the FDA (Food and Drug Administration), the APHIS (Animal Plant Health Inspection Service), and the EPA.
Chapter Dental Public Health & Research Contemporary Practice for the Dental Hygienist Copyright ©2011 by Pearson Education, Inc. All rights reserved.
Government Regulatory Agencies and Impact on Consumer Choices Presentation.
Lesson 2 Good Production Practice #2 Use a veterinarian/client/patient relationship (VCPR) as the basis for medication decision-making.
Introduction to Business © Thomson South-Western ChapterChapter Economic Decisions and Systems Economic Systems and Monopolies Supply and.
Section 6.1 Government and Laws Chapter 6 legal and ethical issues Section 6.2 Social Responsibilities and Ethics.
CIS 170 MART Teaching Effectively/cis170mart.com FOR MORE CLASSES VISIT HCA 497 MART Inspiring Minds/hca497mart.com FOR MORE CLASSES.
HCA 497 MART Experience Tradition /hca497mart.com FOR MORE CLASSES VISIT
HCA 497 NERD Real Success HCA 497 Entire Course (Ash) FOR MORE CLASSES VISIT HCA 497 Week 1 DQ 1 U.S. Health Care System vs. Other.
CJA 464 Week 1 DQ 3 NEW Check this A+ tutorial guideline at 464-NEW/CJA-464-Week-1-DQ-3-NEW What is a legislatively.
HCA 497 Week 2 Quality Oversight in Health Care Organizations Check this A+ tutorial guideline at
HCA 497 Week 4 DQ 2 Technology and Health Care Check this A+ tutorial guideline at ASH/HCA-497-Week-4-DQ-2-Technology-and-
iHEA 9th World Congress Sydney, July 8, 2013
Drug Update – Pharmacy Impacts 2011
Archie B. Carroll Ann K. Buchholtz
Biotechnology Chemical Pharmaceutical Customer Partnership
The Basics of Pharmacy Benefit Management (PBM)
Employers Round Table…
HCS 539 MENTOR Education Your Life - hcs539mentor.com.
Prescription for Pharmaceutical Reform: Healing an Ailing System
LT: Explain the roles government plays in our free enterprise system
AIKTC - School of Pharmacy
Safety plan.
Professional Organizations
LT: Explain the roles government plays in our free enterprise system
Identify the roles government plays in our free enterprise system
Identify the roles government plays in our free enterprise system
Situation & Environmental Analysis
Presentation transcript:

Health Services Organization and Management HSA 500 The Pharmaceutical Industry Williams, S. J., & Torrens, P. R. (2008). Introduction to Health Services (7 th ed.). New York: Cengage Delmar Learning.

Objectives Upon completion of this lesson, you will be able to: –Explain the impact that policy, social and financial forces have on health care access and quality of care in the United States –Explain the major components of the U.S. health care system, their functions, and the relationships among these components

Pharmaceuticals and Health Promotion Pharmaceutical and health gains Biotechnology and pharmaceuticals

Regulatory, Legal Issues and Drug testing Food and Drug Administration –Preclinical safety assessment –Preapproval safety assessment in humans –Safety assessment during FDA review –Postmarking safety surveillance Clinical studies

Check Your Understanding

Research and Development Research-based pharmaceutical Pharmaceutical Invention

Utilization of Drugs Access Pricing and Patent issues

Check Your Understanding

Summary Pharmaceutical and health promotion Regulatory, Legal Issues and Drug testing Research and Development Utilization of Drugs